Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. scores highest on Nitro (65) and lowest on Anchor (40). Its PosiPenta is 47.70 out of 100, around the middle of similar companies.
On the Penta Grid this week, Xilio Therapeutics, Inc. is Grid #320 of 837 in the Healthcare sector in United States, and Grid #2,145 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 47.70 | 42 | 42 | 65 | 49 | 40 |
| Elicio Therapeutics, Inc. | 20.77 | 13 | 34 | 7 | 7 | 43 |
| Pliant Therapeutics, Inc. | 39.18 | 47 | 36 | 31 | 46 | 36 |
| Rein Therapeutics Inc. | 34.66 | 13 | 37 | 25 | 59 | 39 |
| MiNK Therapeutics, Inc. | 47.18 | 0 | 32 | 47 | 94 | 64 |
| Talphera, Inc. | 44.09 | 17 | 50 | 69 | 27 | 58 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -14.49 |
| P/B ratio | 0.78 |
EEarnings
| Trailing EPS | ₹-55.88 |
| Forward EPS | ₹-54.93 |
NNitro
| Price | 809.81 |
| 52-week high | 1192.08 |
| 52-week low | 612.62 |
| Fall from 52-week high | 32.1% |
TTorque
| Return on equity (ROE) | -55.03% |
| Debt-to-equity | 0.09 |
AAnchor
| Beta (price swings) | -0.12 |
| Market cap | ₹532 Cr |
| Insider holding | 25.98% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Xilio Therapeutics, Inc.'s PosiPenta score?
Xilio Therapeutics, Inc.'s PosiPenta is 47.70 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Xilio Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Xilio Therapeutics, Inc. is Grid #320 of 837 in the Healthcare sector in United States, and Grid #2,145 of 4,000 in United States.
Which PosiPenta pillar is strongest for Xilio Therapeutics, Inc.?
Nitro (momentum), with a score of 65 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Xilio Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 40 out of 100: weaker than most similar companies.
Has Xilio Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.28 points, from 45.42 to 47.70.
PositoAI is for research and education only and is not investment advice.